GlassScriptPhysician profile
Cleo Deason
NPI 1881077808
$480.10
in general payments reported to CMS, 2019-2025
13 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.67 · 2022: $115 · 2023: $86.48 · 2024: $126 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $155.12 | 2021-2024 | Collagenase Santyl, Regranex |
| Biowound Solutions, INC. | $64.42 | 2025 | Bio-Connekt |
| Convatec INC. | $50.10 | 2024-2025 | |
| Integra Lifesciences Corporation | $35.31 | 2021-2023 | Tcc-Ez |
| Paratek Pharmaceuticals, INC. | $30.83 | 2022-2024 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $21.56 | 2024 | |
| Reprise Biomedical, INC. | $20.91 | 2024 | Miro3d |
| Solventum Corporation | $20.38 | 2025 | Activ.A.C. |
| Abbvie INC. | $19.14 | 2024 | |
| Evoke Pharma, INC. | $18.74 | 2025 | |
| Kci USA, INC. | $17.21 | 2023 | V.A.C. Dermatac, Activ.A.C. |
| Boston Scientific Corporation | $13.68 | 2022 | |
| Innocoll Pharmaceuticals Limited | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cleo Deason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.